What is Nephrotic Syndrome?
Nephrotic Syndrome is a clinical condition characterized by a group of symptoms that indicate significant damage to the kidneys' filtering units, known as the glomeruli. It is defined by four key features: massive proteinuria (typically >3.5 g/day), hypoalbuminemia, generalized edema, and hyperlipidemia. This condition can affect individuals of all ages but is particularly common in children due to minimal change disease and in adults due to systemic conditions such as diabetes or lupus. The syndrome reflects an underlying defect in the glomerular filtration barrier, allowing large amounts of protein to leak into the urine.
.png "Nephrotic Syndrome")
Table of Contents
Causes of Nephrotic Syndrome
Nephrotic Syndrome is not a disease in itself but a manifestation of various underlying renal or systemic conditions that affect the glomerular filtration barrier. This barrier, made up of endothelial cells, the glomerular basement membrane, and podocytes, is responsible for preventing the loss of proteins in the urine. When it becomes damaged, it leads to massive proteinuria, a hallmark of Nephrotic Syndrome.
The causes of Nephrotic Syndrome can be broadly categorized into primary (idiopathic) glomerular diseases and secondary causes resulting from systemic illnesses, medications, or infections.
1. Primary Glomerular Diseases
These are diseases that primarily affect the kidney's glomeruli, without any identifiable systemic illness. They are the most common cause of nephrotic syndrome, especially in children.
🔹 Minimal Change Disease (MCD)
🔹 Focal Segmental Glomerulosclerosis (FSGS)
🔹 Membranous Nephropathy
🔹 Membranoproliferative Glomerulonephritis (MPGN)
A. Minimal Change Disease
Minimal change disease is a type of glomerular disease that is characterized by minimal changes to the glomeruli under the microscope. It is the most common cause of nephrotic syndrome in children and has a good prognosis.
The prognosis for individuals with minimal change disease is excellent, with up to 90% of patients achieving complete remission with treatment. In most cases, treatment involves corticosteroids, which are highly effective at reducing proteinuria and preventing relapse.
While the prognosis for minimal change disease is generally good, there is a risk of relapse, especially in younger patients. Individuals with this condition need to continue follow-up care with their healthcare provider to monitor for relapse and adjust treatment as needed.
B. Focal Segmental Glomerulosclerosis (FSGS)
Focal segmental glomerulosclerosis (FSGS) is a type of glomerular disease that affects a portion of the glomeruli. It is a leading cause of chronic kidney disease and end-stage renal disease in adults, with a poorer prognosis compared to minimal change disease.
The prognosis for individuals with FSGS varies depending on the severity of the disease and the response to treatment. In some cases, FSGS can be managed with medications such as corticosteroids or immunosuppressants. However, approximately half of the patients with FSGS will progress to end-stage renal disease within 10 years of diagnosis.
The prognosis for FSGS is worse in patients who do not respond to treatment or who experience frequent relapses. In these cases, renal replacement therapy, such as dialysis or kidney transplantation, may be necessary.
C. Membranous Nephropathy
Membranous nephropathy is a type of glomerular disease characterized by the thickening of the glomerular basement membrane. It is the most common cause of nephrotic syndrome in adults and has a variable prognosis.
The prognosis for membranous nephropathy depends on several factors, including the underlying cause and the severity of proteinuria. In some cases, membranous nephropathy can be self-limited or respond well to immunosuppressive therapy, leading to complete remission.
However, in other cases, membranous nephropathy can progress to chronic kidney disease and end-stage renal disease. Approximately 30% of patients with membranous nephropathy will progress to end-stage renal disease within 10-20 years of diagnosis.
D. Membranoproliferative Glomerulonephritis (MPGN)
Membranoproliferative Glomerulonephritis (MPGN) is a distinct pattern of glomerular injury that affects both the nephrotic and nephritic spectrum, meaning patients may present with significant proteinuria (as in nephrotic syndrome), hematuria, and features of inflammation such as hypertension and reduced kidney function (as in nephritic syndrome). MPGN is characterized histologically by mesangial cell proliferation and thickening of the capillary walls due to immune complex deposition or complement dysregulation. This gives a characteristic "tram-track" appearance on light microscopy, caused by duplication of the glomerular basement membrane.
There are multiple types of MPGN, with classification traditionally based on electron microscopy findings, but now increasingly linked to underlying pathogenic mechanisms. A key feature of MPGN is its frequent association with complement abnormalities, particularly in cases involving dysregulation of the alternative complement pathway (such as in C3 glomerulopathy). MPGN may also occur secondary to chronic infections—most notably hepatitis C virus (HCV)—as well as autoimmune conditions or monoclonal gammopathies. In HCV-associated MPGN, immune complexes containing viral antigens deposit in the glomeruli, initiating inflammation.
Management of MPGN focuses on treating the underlying cause (such as antiviral therapy for hepatitis C), controlling blood pressure and proteinuria with renin-angiotensin system inhibitors, and using immunosuppressive therapy in selected cases. The prognosis can be variable, depending on the underlying etiology and response to treatment.
2. Secondary Glomerular Disease
Secondary glomerular disease is another common cause of the nephrotic syndrome. Secondary glomerular disease refers to conditions that affect the kidneys as a result of another underlying disease or condition.
A. Diabetes
Diabetes is a chronic condition that occurs when the body is unable to produce or use insulin effectively. Over time, high levels of glucose in the blood can damage the small blood vessels in the kidneys, including the glomeruli. This damage can lead to secondary glomerular disease, including nephrotic syndrome.
Read more: Diabetic Nephropathy
B. Lupus
Lupus, or systemic lupus erythematosus (SLE), is an autoimmune disease that can affect many parts of the body, including the kidneys. In some cases, lupus can cause inflammation in the glomeruli, leading to secondary glomerular disease. Lupus nephritis is a form of secondary glomerular disease that affects up to 60% of people with lupus.
Read more: What is Lupus?
C. Amyloidosis
Amyloidosis is a rare condition in which abnormal proteins called amyloids build up in the body's tissues and organs, including the kidneys. When amyloids build up in the glomeruli, they can cause damage and lead to secondary glomerular disease. Amyloidosis is more common in older adults and people with a family history of the condition.
D. Multiple Myeloma and Nephrotic Syndrome
Multiple myeloma, a malignancy of plasma cells, can lead to nephrotic syndrome primarily through the deposition of light chains in the glomeruli. These monoclonal light chains are filtered by the kidneys and can accumulate within renal structures, causing direct toxicity and inflammation. This results in damage to the glomerular basement membrane and leads to nephrotic-range proteinuria, a hallmark of nephrotic syndrome in affected patients.
3. Additional Causes of Nephrotic Syndrome
In addition to the causes of nephrotic syndrome due to primary and secondary glomerular disease, the following can also cause nephrotic syndrome.
A. Infections as a Cause of Nephrotic Syndrome
Several infections are known to cause or contribute to nephrotic syndrome either directly or indirectly. Hepatitis B and Hepatitis C viruses are well-established culprits due to their ability to trigger immune complex-mediated glomerular injury. HIV is another important infectious cause, leading to HIV-associated nephropathy (HIVAN), particularly in individuals of African descent. Syphilis and malaria—especially infections caused by Plasmodium malariae—have also been implicated. In these cases, nephrotic syndrome results from either immune responses targeting the infectious agent or from the deposition of immune complexes within the kidney’s filtration system.
B. Drugs and Toxins
Certain medications and toxins have been associated with the development of nephrotic syndrome. Among the most common culprits are non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which can cause minimal change disease or membranous nephropathy. Other drugs such as penicillamine, gold salts, heroin, interferon, and lithium can also induce glomerular damage. The underlying mechanisms vary and may include allergic-type immune reactions, toxic effects on podocytes, or alterations in glomerular permeability.
C. Malignancies and Nephrotic Syndrome
Malignancies, particularly in adults, are an important cause of nephrotic syndrome. Solid tumors, including those of the lung, colon, and breast, have been associated with membranous nephropathy. Lymphomas, particularly Hodgkin’s lymphoma, have a strong link with minimal change disease, a common form of nephrotic syndrome. The association is believed to involve the release of circulating factors from the tumor that alter glomerular permeability or trigger immune-mediated glomerular injury.
D. Genetic and Congenital Disorders
In children, especially infants, congenital and hereditary conditions are significant causes of nephrotic syndrome. One classic example is congenital nephrotic syndrome of the Finnish type, caused by mutations in the NPHS1 gene, which codes for nephrin, a key protein in the slit diaphragm of podocytes. Alport syndrome, a hereditary disorder involving mutations in collagen IV genes, presents with nephritis and is commonly associated with sensorineural hearing loss. Fabry disease, an X-linked lysosomal storage disorder, leads to the accumulation of globotriaosylceramide in various tissues, including the kidneys, ultimately resulting in proteinuria and progressive renal dysfunction.
Pathophysiology of Nephrotic Syndrome
Nephrotic syndrome is a clinical condition characterized by massive proteinuria (>3.5 g/day), hypoalbuminemia, hyperlipidemia, and edema. The pathophysiological basis of this syndrome revolves around damage to the glomerular filtration barrier, leading to increased permeability to plasma proteins, particularly albumin. The disease process can be triggered by various causes including primary glomerular diseases, systemic illnesses, infections, drugs, and genetic mutations.
1. Glomerular Filtration Barrier Dysfunction
The glomerular filtration barrier is composed of three main layers:
✔ The fenestrated endothelium
✔ The glomerular basement membrane (GBM)
✔ The podocytes with their slit diaphragms
In nephrotic syndrome, this barrier becomes dysfunctional. The most common site of injury is the podocyte (visceral epithelial cell), especially the slit diaphragm that regulates the filtration of proteins. When podocytes are damaged (as in minimal change disease or focal segmental glomerulosclerosis), they undergo effacement (flattening of foot processes), losing their structural integrity and function.
This leads to increased permeability to proteins, allowing large amounts of albumin and other plasma proteins to leak into the urine, resulting in proteinuria.
2. Proteinuria and Hypoalbuminemia
As albumin is lost through the urine, serum albumin levels drop, leading to hypoalbuminemia. Albumin plays a major role in maintaining oncotic (colloid osmotic) pressure in the vascular compartment. When albumin levels decrease, the oncotic pressure also decreases, resulting in fluid shifting from the intravascular to the interstitial space, which causes edema.
This protein loss is not limited to albumin; other important proteins such as antithrombin III, transferrin, and immunoglobulins are also lost, leading to further complications like hypercoagulability, anemia, and increased infection risk.
3. Edema Formation
Edema in nephrotic syndrome is multifactorial:
✔ The primary mechanism is the reduced oncotic pressure due to hypoalbuminemia, which draws water into the interstitial space.
✔ The secondary mechanism involves renal sodium and water retention, driven by perceived intravascular volume depletion. The kidneys activate the renin-angiotensin-aldosterone system (RAAS), antidiuretic hormone (ADH), and sympathetic nervous system, leading to further retention of sodium and water, exacerbating the edema.
4. Hyperlipidemia and Lipiduria
The liver responds to hypoalbuminemia by increasing synthesis of lipoproteins, particularly very low-density lipoproteins (VLDL) and low-density lipoproteins (LDL). This compensatory mechanism leads to hyperlipidemia, especially elevated cholesterol and triglycerides.
In addition, due to damage to the filtration barrier, lipoproteins may also spill into the urine, resulting in lipiduria, which can be seen microscopically as fatty casts or oval fat bodies ("Maltese cross" appearance under polarized light).
5. Hypercoagulable State
Nephrotic syndrome is a prothrombotic condition. Several mechanisms contribute to this:
✔ Loss of anticoagulant proteins, especially antithrombin III, protein C, and protein S
✔ Increased levels of procoagulant factors like fibrinogen and factors V and VIII
✔ Increased platelet aggregation and adhesiveness
✔ Hemoconcentration due to fluid shifts
These changes increase the risk of thromboembolic complications, such as renal vein thrombosis, deep vein thrombosis, and pulmonary embolism.
6. Immunodeficiency
Loss of immunoglobulins (particularly IgG) in the urine impairs the immune response, rendering patients more susceptible to infections. This can include respiratory tract infections, peritonitis (especially in children), and sepsis.
Additionally, the use of immunosuppressive therapy in some cases further exacerbates this risk.
7. Other Consequences
Anemia: Due to urinary losses of transferrin and possibly erythropoietin resistance.
Vitamin D Deficiency: Loss of vitamin D-binding protein in urine can result in hypocalcemia and secondary hyperparathyroidism.
Hypothyroidism: Loss of thyroxine-binding globulin can affect thyroid hormone levels.
The pathophysiology of nephrotic syndrome involves a cascade of events starting with glomerular injury and increased permeability to proteins, particularly albumin. The resulting proteinuria sets off systemic consequences such as hypoalbuminemia, edema, hyperlipidemia, hypercoagulability, and immune dysfunction.(alert-passed)
Characteristics of Nephrotic Syndrome
Nephrotic Syndrome is a clinical condition that arises due to damage to the glomerular filtration barrier in the kidneys. This damage leads to excessive protein loss in the urine and sets off a cascade of physiological responses.
The following are the characteristic features of nephrotic syndrome:
1. Massive Proteinuria
One of the primary characteristics of Nephrotic Syndrome is massive proteinuria, typically defined as urinary protein excretion exceeding 3.5 grams per day in adults (or ≥40 mg/m²/hour in children). The protein lost is mainly albumin, which plays a vital role in maintaining plasma oncotic pressure. Proteinuria occurs due to increased permeability of the glomerular basement membrane, allowing plasma proteins to pass into the urine. Urine may appear frothy or foamy, which is often a visual clue to the presence of excess protein.
2. Hypoalbuminemia
As a direct consequence of proteinuria, there is a marked reduction in serum albumin levels, typically below 3.0 g/dL. Albumin is essential for maintaining oncotic pressure within blood vessels, and its loss leads to a fluid shift from the intravascular compartment to the interstitial space. This is a central mechanism behind the development of edema in Nephrotic Syndrome. The liver attempts to compensate by increasing albumin synthesis, but this is often insufficient to restore normal levels due to ongoing urinary losses.
3. Edema
Generalized edema (anasarca) is one of the most clinically apparent features of Nephrotic Syndrome. It is often first seen as periorbital puffiness, especially in the morning, and later involves the lower limbs, abdomen (ascites), and even pleural effusions in severe cases. The edema results from the fall in plasma oncotic pressure due to hypoalbuminemia and sodium retention by the kidneys. It can be quite dramatic, especially in children and in advanced cases.
4. Hyperlipidemia and Lipiduria
Another notable feature is hyperlipidemia, characterized by elevated levels of cholesterol, triglycerides, and lipoproteins in the blood. This occurs as a compensatory response by the liver to hypoalbuminemia, which increases the synthesis of lipoproteins. The resulting dyslipidemia is often significant and contributes to long-term cardiovascular risk. Additionally, lipiduria—the presence of lipids in the urine—may be observed. Under the microscope, this appears as oval fat bodies or "Maltese crosses" in polarized light.
5. Hypercoagulability
Patients with Nephrotic Syndrome are at increased risk of thromboembolic events, including renal vein thrombosis, deep vein thrombosis (DVT), and pulmonary embolism. This hypercoagulable state is multifactorial, involving the loss of anticoagulant proteins like antithrombin III, increased platelet aggregation, and enhanced synthesis of clotting factors by the liver. The risk is highest when serum albumin levels fall below 2.0 g/dL.
6. Increased Susceptibility to Infections
Nephrotic Syndrome compromises the immune system due to urinary loss of immunoglobulins (especially IgG) and components of the complement system. This results in a higher risk of bacterial infections, particularly pneumococcal infections, peritonitis, and cellulitis. Vaccinations and prompt treatment of infections are essential components of care.
7. Other Metabolic Abnormalities
Additional metabolic changes may include hypocalcemia (due to loss of vitamin D-binding protein in urine), iron deficiency, and micronutrient losses. Some patients may also present with hypothyroidism, either due to loss of thyroid-binding globulins or as a preexisting condition.
Symptoms of Nephrotic Syndrome
Nephrotic Syndrome is a clinical condition that presents with a characteristic group of symptoms due to excessive protein loss through the urine. These symptoms arise primarily from the underlying pathophysiological changes in the glomerular filtration barrier, resulting in proteinuria, hypoalbuminemia, and their systemic consequences. The severity of symptoms can vary depending on the cause, duration, and extent of the disease.
1. Generalized Edema (Swelling)
Edema is the most prominent and often the first symptom noticed in nephrotic syndrome. It is initially seen around the eyes, especially in the morning (periorbital edema), and may progress to generalized swelling of the body (anasarca), including legs, ankles, abdomen (ascites), and even the scrotum or labia. The swelling is soft, pitting, and often worsens as the day progresses or with prolonged standing. This occurs due to low plasma oncotic pressure from hypoalbuminemia, which allows fluid to leak into the interstitial space.
2. Foamy or Frothy Urine
Patients often notice that their urine appears foamy or bubbly, which is a visual clue of significant proteinuria. This frothiness results from the presence of excess proteins in the urine, particularly albumin, which reduces surface tension and causes bubbles to form. Although this is not a definitive diagnostic feature, it is commonly reported by patients.
3. Fatigue and Weakness
Chronic protein loss and the resulting hypoalbuminemia can lead to fatigue, muscle wasting, and a general sense of weakness. The underlying systemic inflammation, fluid overload, and potential anemia also contribute to low energy levels and reduced exercise tolerance.
4. Weight Gain
Despite a possible loss of muscle mass due to protein deficiency, patients often experience unexplained weight gain due to fluid retention. This weight gain can be quite rapid and is usually due to accumulating edema rather than increased fat or muscle mass.
5. Decreased Urine Output
Although not always present, oliguria (decreased urine output) can occur in some individuals, especially if fluid is retained in the body. This may be more noticeable in children with severe edema or those approaching acute kidney injury.
6. Signs of Hyperlipidemia
Hyperlipidemia is a hallmark of nephrotic syndrome, although it may not present with obvious symptoms initially. In rare cases, xanthomas (fatty deposits under the skin) or xanthelasma (yellowish plaques around the eyelids) may develop, particularly in long-standing, untreated cases with very high cholesterol levels.
7. Increased Susceptibility to Infections
Due to the loss of immunoglobulins (especially IgG) in the urine and impaired immune response, patients with nephrotic syndrome are more susceptible to recurrent infections, such as cellulitis, pneumonia, urinary tract infections, and in children, spontaneous bacterial peritonitis. These infections can present with fever, malaise, or localized signs depending on the site affected.
8. Symptoms of Thromboembolic Events
A hypercoagulable state may lead to thrombotic complications, including deep vein thrombosis (DVT), pulmonary embolism, or renal vein thrombosis. Symptoms can include sudden leg pain or swelling, chest pain, shortness of breath, or flank pain. These complications are medical emergencies and can be life-threatening if not promptly diagnosed and treated.
9. Nutritional Deficiencies
The loss of essential proteins in the urine can also result in nutritional deficiencies, including iron deficiency (contributing to anemia), vitamin D deficiency (due to loss of vitamin D-binding protein), and possibly hypocalcemia. These may manifest as pale skin, brittle nails, muscle cramps, or bone pain in advanced stages.
Nephrotic syndrome presents with a variety of symptoms, primarily driven by massive proteinuria and its consequences. These include edema, foamy urine, fatigue, weight gain, and susceptibility to infections and thrombotic events. Early recognition of these symptoms is essential to initiate prompt diagnosis and treatment, which can help prevent complications and slow disease progression.(alert-passed)
Complications of Nephrotic Syndrome
Nephrotic Syndrome, though primarily a kidney disorder marked by heavy proteinuria, hypoalbuminemia, and edema, can lead to a wide range of systemic complications. These arise from the loss of essential proteins in the urine, immune dysfunction, altered lipid metabolism, and changes in fluid balance. Some complications are acute and life-threatening, while others develop over time and can contribute to chronic health issues.
1. Infections
One of the most significant and potentially life-threatening complications of nephrotic syndrome is an increased risk of infections. This susceptibility is primarily due to the urinary loss of immunoglobulins (especially IgG) and complement proteins, which are crucial for immune defense. Common infections include peritonitis (especially in children), cellulitis, urinary tract infections, and pneumonia. Infections may be severe and recurrent, and prompt recognition and treatment are essential.
2. Thromboembolic Events
Nephrotic syndrome is associated with a hypercoagulable state, due to the urinary loss of anticoagulant proteins such as antithrombin III, protein C, and protein S, as well as increased fibrinogen and platelet activation. This makes patients prone to developing deep vein thrombosis (DVT), pulmonary embolism, and renal vein thrombosis, which can present with flank pain, hematuria, or acute kidney injury. These events are medical emergencies requiring anticoagulation therapy.
3. Acute Kidney Injury (AKI)
Some patients with nephrotic syndrome may develop acute kidney injury, particularly if they become volume-depleted due to overuse of diuretics or during episodes of infection or thrombosis. The kidney’s filtration function may abruptly decline, leading to reduced urine output, fluid overload, and rising creatinine levels. This can complicate the management of the underlying disease and may require hospitalization.
4. Chronic Kidney Disease (CKD)
In cases where the underlying cause of nephrotic syndrome is progressive—such as focal segmental glomerulosclerosis (FSGS) or membranoproliferative glomerulonephritis (MPGN)—there is a risk of progression to chronic kidney disease. Persistent proteinuria and ongoing glomerular injury can slowly impair renal function, eventually leading to end-stage renal disease (ESRD) requiring dialysis or kidney transplantation.
5. Hyperlipidemia and Atherosclerosis
Nephrotic syndrome causes significant dysregulation of lipid metabolism, resulting in elevated levels of total cholesterol, LDL, triglycerides, and lipoprotein(a). This state of hyperlipidemia is not only a diagnostic feature but also a long-term cardiovascular risk. Over time, these lipid abnormalities may contribute to atherosclerosis, coronary artery disease, and stroke, especially if left untreated.
6. Protein Malnutrition and Cachexia
Heavy urinary protein losses can result in hypoalbuminemia and generalized protein-energy malnutrition. In prolonged or severe cases, this can lead to muscle wasting, fatigue, poor wound healing, and growth retardation in children. Malnutrition may also worsen immune suppression and delay recovery from infections or surgery.
7. Hypocalcemia and Bone Disease
Loss of vitamin D-binding proteins and albumin in the urine can impair calcium absorption and vitamin D metabolism, potentially resulting in hypocalcemia. Long-standing nephrotic syndrome can lead to secondary hyperparathyroidism and renal osteodystrophy, increasing the risk of bone pain, fractures, and growth impairment in children.
8. Anemia
Several factors contribute to anemia in nephrotic syndrome. These include loss of transferrin, reduced erythropoietin production in CKD, iron deficiency, and chronic inflammation. Anemia may worsen fatigue and cardiovascular burden in affected individuals.
9. Hypovolemia
Despite edema and apparent fluid overload, patients with nephrotic syndrome can develop intravascular volume depletion, especially when diuretics are overused or during intercurrent illnesses. This can lead to hypotension, acute kidney injury, and poor perfusion of vital organs.
10. Drug Toxicity
Patients with nephrotic syndrome often require long-term medications, including diuretics, corticosteroids, immunosuppressants, and lipid-lowering agents. These drugs can cause various side effects, such as steroid-induced diabetes, infections, Cushingoid features, and hepatotoxicity, necessitating careful monitoring and dose adjustment.
Nephrotic syndrome is associated with a spectrum of complications that can impact nearly every body system. From life-threatening infections and thrombosis to chronic conditions like malnutrition, anemia, and progressive kidney failure, these complications highlight the need for early diagnosis, close monitoring, and multidisciplinary care.(alert-passed)
Diagnosis of Nephrotic Syndrome
Nephrotic syndrome is a clinical condition characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia. The diagnosis involves a combination of clinical evaluation, laboratory investigations, and sometimes kidney biopsy, depending on the age of the patient, severity of symptoms, and suspected underlying cause. Early and accurate diagnosis is crucial for guiding treatment and preventing complications.
1. Clinical Evaluation
The diagnostic process begins with a thorough history and physical examination. Patients typically present with generalized edema, which often starts in the face (especially around the eyes) and progresses to the lower limbs and abdomen. The edema may be pitting in nature and can cause weight gain and reduced urine output. In children, periorbital swelling may be the first visible sign. Clinicians should inquire about recent infections, drug use, autoimmune symptoms, or malignancy signs to help determine the potential cause of nephrotic syndrome.
2. Urinalysis and Protein Quantification
Urinalysis is the cornerstone of nephrotic syndrome diagnosis. It typically reveals massive proteinuria, often described as nephrotic-range proteinuria, which is defined as ≥3.5 grams of protein loss per 24 hours in adults or ≥40 mg/m²/hour in children. A dipstick test may initially detect proteinuria, but quantification through a 24-hour urine collection or spot urine protein-to-creatinine ratio (UPCR) provides more accurate results.
Microscopic hematuria may also be present in some cases, though it is more common in conditions that also involve a nephritic component. Casts (especially fatty casts or oval fat bodies) may be observed on microscopic examination of urine sediment and are suggestive of nephrotic syndrome.
3. Blood Tests
Blood investigations support the diagnosis and assess the severity and complications:
🔹 Serum Albumin: A hallmark feature is hypoalbuminemia, typically <3.0 g/dL due to protein loss in the urine.
🔹 Serum Cholesterol and Lipid Profile: Patients often exhibit hyperlipidemia, including elevated total cholesterol, LDL, and triglycerides.
🔹 Renal Function Tests: Blood urea nitrogen (BUN) and serum creatinine levels help assess kidney function.
🔹 Complete Blood Count (CBC): May show anemia or signs of infection.
🔹 Coagulation Profile: Hypercoagulability is a concern in nephrotic syndrome, and abnormalities such as elevated fibrinogen or low antithrombin III may be seen.
4. Additional Laboratory Tests
To identify the underlying cause of nephrotic syndrome, additional targeted tests are conducted based on clinical suspicion:
🔹 Autoimmune Screen: Antinuclear antibody (ANA), anti-dsDNA, ANCA, and complement levels (C3, C4) are checked if systemic lupus erythematosus (SLE) or vasculitis is suspected.
🔹 Infectious Disease Workup: Screening for Hepatitis B, Hepatitis C, and HIV is essential, as these infections are associated with certain types of glomerular disease.
🔹 Serum and Urine Protein Electrophoresis: Especially useful in adults to detect monoclonal proteins in cases like multiple myeloma or amyloidosis.
🔹 Genetic Testing: In infants and young children with congenital nephrotic syndrome, genetic tests may be conducted to identify mutations such as those in the NPHS1, NPHS2, or WT1 genes.
5. Imaging Studies
Although not essential for diagnosis, renal ultrasound is often performed to assess kidney size and rule out structural abnormalities. Kidneys in nephrotic syndrome may appear enlarged with increased echogenicity. Imaging may also detect complications like renal vein thrombosis.
6. Kidney Biopsy
A renal biopsy is typically indicated in:
🔹 Adults with new-onset nephrotic syndrome to identify the underlying glomerular pathology.
🔹 Children >12 years, or those with atypical features such as hematuria, hypertension, or low complement levels.
🔹 Steroid-resistant cases in children (i.e., no response to corticosteroid therapy after 4–8 weeks).
🔹 Suspected secondary causes (e.g., lupus nephritis, amyloidosis, membranoproliferative GN).
Biopsy provides a definitive histological diagnosis, helping to differentiate between minimal change disease, focal segmental glomerulosclerosis (FSGS), membranous nephropathy, and other glomerular diseases. Immunofluorescence and electron microscopy may be used to further classify disease types.
7. Diagnostic Criteria Summary
A diagnosis of nephrotic syndrome is typically made when the following four core features are present:
🔹 Proteinuria ≥3.5 g/day (or ≥300 mg/mmol spot UPCR)
🔹 Hypoalbuminemia (<3 g/dL)
🔹 Edema
🔹 Hyperlipidemia
Additional findings (e.g., lipiduria, casts, hypertension, renal dysfunction) help define the underlying cause and disease severity.
Once a diagnosis has been made, treatment can be tailored to the underlying cause and severity of the condition.
Diagnosing nephrotic syndrome involves a multifaceted approach combining clinical assessment, urine and blood analysis, and sometimes kidney biopsy. Identifying the underlying cause is essential, as it guides treatment decisions and helps predict prognosis. Prompt diagnosis not only enables early treatment but also minimizes the risk of complications such as infections, thromboembolism, and progression to chronic kidney disease.(alert-passed)
Treatment of Nephrotic Syndrome
The treatment of Nephrotic Syndrome (NS) aims to reduce proteinuria, control symptoms, manage underlying causes, and prevent complications such as infections, thromboembolism, and progression to chronic kidney disease. Treatment strategies depend on whether the condition is primary (idiopathic) or secondary to systemic disease, and on the patient’s age, underlying pathology, and response to initial therapy.
A. Initial Step in Managing Nephrotic Syndrome
The first step in treating nephrotic syndrome is to identify and treat the underlying cause of the condition. For example, if the condition is caused by diabetes, treatment may involve controlling blood sugar levels to prevent further damage to the kidneys. Similarly, if the condition is caused by lupus, treatment may involve medications to suppress the immune system and reduce inflammation.
B. General Supportive Management
Regardless of the underlying cause, all patients with nephrotic syndrome require supportive care to manage symptoms and prevent complications.
🔷 Edema Management: Edema, often a prominent and distressing symptom, is managed with dietary sodium restriction and fluid limitation. In cases of significant fluid overload, loop diuretics such as furosemide are commonly used. Sometimes, thiazide diuretics or aldosterone antagonists (e.g., spironolactone) are added for synergy.
🔷 Proteinuria Reduction: Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are first-line medications to reduce proteinuria and preserve kidney function. These drugs lower intraglomerular pressure, reduce protein loss in the urine, and may have long-term renoprotective effects.
🔷 Lipid Control: Hyperlipidemia is a common finding and may be treated with statins or other lipid-lowering agents, especially in adults or those with a high cardiovascular risk. Lifestyle changes, including a low-fat die,t are also advised.
🔷 Anticoagulation: Because nephrotic syndrome is associated with a hypercoagulable state, patients with additional thrombotic risk factors (e.g., serum albumin <2 g/dL, history of thrombosis, prolonged immobilization) may require prophylactic anticoagulation. If thrombosis is confirmed (e.g., renal vein thrombosis, deep vein thrombosis), therapeutic anticoagulation is initiated.
🔷 Infection Prevention: Due to the loss of immunoglobulins in the urine and immunosuppressive therapy, patients are more prone to infections. Pneumococcal and influenza vaccines are recommended. Prophylactic antibiotics may be considered in high-risk situations, especially in children.
C. Corticosteroid Therapy
Corticosteroids are the mainstay of treatment for many types of primary nephrotic syndrome, particularly Minimal Change Disease (MCD) and some cases of Focal Segmental Glomerulosclerosis (FSGS).
✔ Children: Most children with idiopathic nephrotic syndrome are presumed to have MCD and are started empirically on oral prednisone (2 mg/kg/day) for 4–6 weeks, followed by a tapering regimen.
✔ Adults: A renal biopsy is usually performed before starting corticosteroids in adults. The dose is typically 1 mg/kg/day of prednisone for several weeks, depending on the underlying pathology.
Patients are monitored for response (i.e., resolution of proteinuria), and the syndrome is classified as steroid-sensitive, steroid-resistant, or steroid-dependent, which influences further treatment.
D. Immunosuppressive Agents
When corticosteroids are not effective, or when patients experience frequent relapses or adverse effects, second-line immunosuppressive agents may be used. The choice depends on the cause and severity of the disease:
🔷 Calcineurin Inhibitors: Cyclosporine and tacrolimus are used particularly in steroid-resistant FSGS and steroid-dependent nephrotic syndrome. These drugs reduce proteinuria but require close monitoring due to potential nephrotoxicity.
🔷 Cyclophosphamide: An alkylating agent often used in steroid-dependent or frequently relapsing cases, especially in children.
🔷 Mycophenolate Mofetil (MMF): Useful in patients with steroid dependence or intolerance, often used as a steroid-sparing agent.
🔷 Rituximab: A monoclonal antibody targeting CD20 on B cells, increasingly used in relapsing or steroid-dependent nephrotic syndrome, particularly in children and some adults.
E. Treatment of Secondary Causes
In cases of secondary nephrotic syndrome, managing the underlying cause is essential:
🔷 Lupus Nephritis: Treated with corticosteroids and immunosuppressants such as cyclophosphamide or mycophenolate.
🔷 Diabetic Nephropathy: Requires strict glycemic control, blood pressure management, and RAAS blockade with ACEIs or ARBs.
🔷 Infections (e.g., Hepatitis B/C, HIV): Antiviral therapy is crucial alongside supportive care.
🔷 Malignancy-associated Nephrotic Syndrome: Addressing the underlying cancer can lead to resolution of the nephrotic features.
F. Dietary and Lifestyle Recommendations
Nutritional support plays a vital role in managing nephrotic syndrome. A key dietary measure is sodium restriction, generally limited to less than 2 grams per day, to help control edema and fluid retention. Protein intake should be moderate, while excessive protein consumption can exacerbate proteinuria, insufficient protein may lead to malnutrition. Therefore, individualized dietary planning with the assistance of a renal dietitian is highly recommended to balance these needs. Additionally, a lipid-lowering diet complements pharmacologic therapies aimed at controlling hyperlipidemia,a commonly associated with nephrotic syndrome. Beyond diet, lifestyle modifications such as smoking cessation, regular exercise, and maintaining a healthy weight are essential to reduce cardiovascular risk, which is elevated in patients with nephrotic syndrome.
G. Monitoring and Follow-Up
Long-term monitoring is critical for patients with nephrotic syndrome to track disease progression and manage complications. Regular urinalysis and proteinuria assessments are necessary to evaluate treatment effectiveness. Kidney function should be closely monitored through serum creatinine levels and estimated glomerular filtration rate (eGFR) measurements. Blood pressure monitoring is also essential, given its impact on kidney health and cardiovascular risk. Periodic lipid profile assessments help manage dyslipidemia, while surveillance for drug toxicity, especially in patients on immunosuppressive medications, is important to prevent adverse effects. Patients with frequent relapses, such as many children and adults with worsening proteinuria, require more intensive and frequent follow-up to adjust treatment and prevent further renal damage.
The treatment of nephrotic syndrome is multifaceted and requires a combination of supportive therapy, immunosuppression, and management of underlying diseases. Individualized care tailored to the patient’s response, age, and pathology ensures the best outcomes. Long-term follow-up is necessary to monitor renal function, prevent complications, and adjust treatment over time.(alert-passed)
Prevention Of Nephrotic Syndrome
There is no guaranteed way to prevent nephrotic syndrome; however, there are some strategies that can help reduce the risk of developing this condition.
A. Control underlying medical conditions: Medical conditions such as diabetes and hypertension can increase the risk of developing nephrotic syndrome. It is important to manage these conditions through lifestyle changes and medications as prescribed by a healthcare professional.
B. Avoid certain medications: Some medications can damage the kidneys and increase the risk of developing nephrotic syndrome. It is important to use medications only as prescribed by a healthcare professional and to inform them of any kidney problems before starting any new medication.
C. Maintain a healthy lifestyle: Eating a healthy diet, staying physically active, maintaining a healthy weight, and avoiding smoking and excessive alcohol consumption can help reduce the risk of developing kidney damage and nephrotic syndrome.
D. Monitor kidney function: Regular check-ups with a healthcare professional can help detect any early signs of kidney damage or dysfunction, allowing for early intervention and management.
E. Manage Infections: Certain infections, such as streptococcal infections, can lead to kidney damage and nephrotic syndrome. It is important to manage infections promptly and effectively to reduce the risk of complications.
F. Avoid exposure to toxins: Exposure to certain toxins, such as heavy metals and chemicals, can damage the kidneys and increase the risk of nephrotic syndrome. It is important to avoid exposure to these toxins as much as possible and to take appropriate precautions in the workplace or other environments where exposure may occur.
It is important to note that some cases of nephrotic syndrome may not be preventable, as they may be due to genetic or autoimmune factors. In these cases, management and treatment options are available to help reduce symptoms and prevent complications.
Prognosis of Nephrotic Syndrome
The prognosis of nephrotic syndrome varies significantly depending on the underlying cause, patient age, response to treatment, and presence of complications. In children, especially those with minimal change disease—the most common cause of nephrotic syndrome in the pediatric population—the prognosis is generally excellent. Most children respond well to corticosteroid therapy, achieving remission within weeks. However, some may experience frequent relapses or steroid dependency, which can complicate long-term management but still typically carry a favorable overall outlook.
Prognosis Based on Underlying Etiology
The prognosis differs markedly in cases caused by other glomerular diseases. For example, focal segmental glomerulosclerosis (FSGS) often has a more guarded prognosis due to frequent steroid resistance and a higher risk of progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD). Similarly, membranous nephropathy, which is more common in adults, may have a variable course—some patients achieve spontaneous remission, while others develop progressive renal impairment.
Secondary causes of nephrotic syndrome, such as those related to systemic diseases (e.g., diabetes mellitus, lupus erythematosus, infections), carry prognoses closely tied to the control of the underlying condition. Poorly controlled systemic illnesses or persistent infections can worsen kidney damage and worsen outcomes.
Long-Term Complications and Impact on Prognosis
Chronic proteinuria and hypoalbuminemia can lead to significant complications that affect prognosis. Persistent nephrotic syndrome increases the risk of thromboembolism, infections, cardiovascular disease, and malnutrition, all of which can contribute to morbidity and mortality. The degree of kidney function impairment at diagnosis and over time is a critical determinant of long-term prognosis. Patients who develop CKD or ESRD may require dialysis or kidney transplantation, profoundly impacting quality of life and survival.
Factors Influencing Prognosis
Several factors influence the prognosis, including early diagnosis, prompt initiation of appropriate therapy, patient adherence to treatment, and effective management of complications. Regular monitoring and follow-up allow for timely adjustments in therapy, reducing the risk of progression and adverse outcomes. Advances in immunosuppressive therapy and supportive care have improved survival rates and quality of life for many patients.
